China Offers Green Channel To Spur Device Innovation, Import Replacement
This article was originally published in PharmAsia News
The newly formed China FDA (CFDA) has proposed a special approval process for medical devices aimed at creating strong domestic players, particularly in the endoscope and medical electronic sectors, by overhauling regulations and procedures.
You may also be interested in...
With vaccines perhaps the ultimate weapon to fight the coronavirus, a developer in China sees a big chunk of investment with potentially more companies to see funding coming.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.